Study of Infigratinib in Children With Achondroplasia

Conditions

• Achondroplasia

Interventions

• DRUG: Infigratinib 0.016 mg/kg
• DRUG: Infigratinib 0.032 mg/kg
• DRUG: Infigratinib 0.064 mg/kg
• DRUG: Infigratinib 0.128 mg/kg
• DRUG: Infigratinib 0.25 mg/kg

Sponsor

QED Therapeutics, a BridgeBio company